Pacific Biosciences of California Overview
Pacific Biosciences of California Target Price
Analysts' 12-month price predictions for PACB.
Share Price
$1.76
Average Target Price
$3.00
70.5% upside
70.5% upside2 analysts in the last 4 months
High: $3.5 | Low: $2.5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-18 | Goldman SachsMatthew Sykes | $2.5 | 42% upside |  |
| 2024-04-16 | Canaccord GenuityKyle Mikson | $3.5 | 98.9% upside | |
| 2022-11-16 | Canaccord Genuity | $14 | 695.5% upside | |
| 2022-08-17 | Piper SandlerDavid Westenberg | $7.5 | 326.1% upside | |
| 2022-05-15 | Piper SandlerDavid Westenberg | $6 | 240.9% upside | |
| 2022-01-12 | Piper SandlerDavid Westenberg | $20 | 1036.4% upside | |